

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.84966175 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.68577508 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.68577508 |
| 4 | tolerance induction (GO:0002507) | 4.94281738 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.54287139 |
| 6 | regulation of gamma-delta T cell activation (GO:0046643) | 4.52476593 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.42821187 |
| 8 | detection of other organism (GO:0098543) | 4.38607189 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 4.35413747 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.35413747 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.35413747 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.35413747 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 4.35413747 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 4.35413747 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.34920387 |
| 16 | response to peptidoglycan (GO:0032494) | 4.32098969 |
| 17 | detection of bacterium (GO:0016045) | 4.28816041 |
| 18 | leukocyte aggregation (GO:0070486) | 4.28684907 |
| 19 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.25732457 |
| 20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.13090114 |
| 21 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.09209703 |
| 22 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.09073445 |
| 23 | positive regulation of tolerance induction (GO:0002645) | 4.02601466 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.01208500 |
| 25 | negative regulation of interleukin-12 production (GO:0032695) | 3.99139492 |
| 26 | regulation of tolerance induction (GO:0002643) | 3.97681205 |
| 27 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.96296287 |
| 28 | neutrophil activation involved in immune response (GO:0002283) | 3.94345349 |
| 29 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.91398614 |
| 30 | negative regulation of T cell mediated immunity (GO:0002710) | 3.86841154 |
| 31 | cellular extravasation (GO:0045123) | 3.85568694 |
| 32 | response to muramyl dipeptide (GO:0032495) | 3.84655300 |
| 33 | macrophage activation involved in immune response (GO:0002281) | 3.77897995 |
| 34 | negative thymic T cell selection (GO:0045060) | 3.74840039 |
| 35 | positive thymic T cell selection (GO:0045059) | 3.73682940 |
| 36 | germinal center formation (GO:0002467) | 3.61571683 |
| 37 | negative T cell selection (GO:0043383) | 3.61387044 |
| 38 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.55126493 |
| 39 | type I interferon signaling pathway (GO:0060337) | 3.50925503 |
| 40 | cellular response to type I interferon (GO:0071357) | 3.50925503 |
| 41 | response to type I interferon (GO:0034340) | 3.48985261 |
| 42 | detection of external biotic stimulus (GO:0098581) | 3.45159493 |
| 43 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.44619687 |
| 44 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.43986484 |
| 45 | immunoglobulin mediated immune response (GO:0016064) | 3.41611903 |
| 46 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.38834142 |
| 47 | B cell receptor signaling pathway (GO:0050853) | 3.38280265 |
| 48 | regulation of T cell tolerance induction (GO:0002664) | 3.38021474 |
| 49 | positive regulation of B cell differentiation (GO:0045579) | 3.37974868 |
| 50 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.31188590 |
| 51 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.31188590 |
| 52 | T cell migration (GO:0072678) | 3.30936188 |
| 53 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.29676129 |
| 54 | response to host immune response (GO:0052572) | 3.29676129 |
| 55 | T cell selection (GO:0045058) | 3.28456895 |
| 56 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.24080433 |
| 57 | positive T cell selection (GO:0043368) | 3.22022892 |
| 58 | thymic T cell selection (GO:0045061) | 3.21661413 |
| 59 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.18014981 |
| 60 | response to host (GO:0075136) | 3.18014981 |
| 61 | response to host defenses (GO:0052200) | 3.18014981 |
| 62 | negative regulation of type 2 immune response (GO:0002829) | 3.17944458 |
| 63 | negative regulation of interleukin-6 production (GO:0032715) | 3.13314740 |
| 64 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.10703614 |
| 65 | defense response to protozoan (GO:0042832) | 3.10076633 |
| 66 | detection of biotic stimulus (GO:0009595) | 3.09002187 |
| 67 | regulation of B cell differentiation (GO:0045577) | 3.07906391 |
| 68 | response to interleukin-15 (GO:0070672) | 3.06152541 |
| 69 | negative regulation of B cell mediated immunity (GO:0002713) | 3.05702637 |
| 70 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.05702637 |
| 71 | neutrophil activation (GO:0042119) | 3.05500575 |
| 72 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.04956946 |
| 73 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.02015521 |
| 74 | positive regulation of granulocyte differentiation (GO:0030854) | 3.01999905 |
| 75 | detection of molecule of bacterial origin (GO:0032490) | 3.00801247 |
| 76 | activated T cell proliferation (GO:0050798) | 2.99920097 |
| 77 | myeloid cell activation involved in immune response (GO:0002275) | 2.99712295 |
| 78 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.99640626 |
| 79 | histone H3-K36 demethylation (GO:0070544) | 2.99063518 |
| 80 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.98264077 |
| 81 | respiratory burst (GO:0045730) | 2.98063180 |
| 82 | regulation of germinal center formation (GO:0002634) | 2.98050023 |
| 83 | microglial cell activation (GO:0001774) | 2.97679779 |
| 84 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.95599495 |
| 85 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.93750959 |
| 86 | negative regulation of adaptive immune response (GO:0002820) | 2.92893775 |
| 87 | regulation of regulatory T cell differentiation (GO:0045589) | 2.91764141 |
| 88 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.90994572 |
| 89 | response to protozoan (GO:0001562) | 2.90099022 |
| 90 | granulocyte activation (GO:0036230) | 2.89739344 |
| 91 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.88237300 |
| 92 | negative regulation of innate immune response (GO:0045824) | 2.84968302 |
| 93 | macrophage activation (GO:0042116) | 2.84273056 |
| 94 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.82743984 |
| 95 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.82379737 |
| 96 | regulation of mast cell degranulation (GO:0043304) | 2.80956749 |
| 97 | Peyers patch development (GO:0048541) | 2.80665948 |
| 98 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.80665948 |
| 99 | B cell mediated immunity (GO:0019724) | 2.76705940 |
| 100 | regulation of necroptotic process (GO:0060544) | 2.76472192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.09959281 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.31784171 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.10025983 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.01983511 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.19728150 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.01522478 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.99986049 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.97618314 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.93336955 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.73468318 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.69211573 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 2.65135986 |
| 13 | MAF_26560356_Chip-Seq_TH1_Human | 2.62160208 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.59116373 |
| 15 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.58560514 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.48542875 |
| 17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.46473522 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.41034589 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.40446120 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 2.38127689 |
| 21 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.31859600 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.28637059 |
| 23 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.27110663 |
| 24 | UTX_26944678_Chip-Seq_JUKART_Human | 2.24534349 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.23785050 |
| 26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.23575285 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.23427242 |
| 28 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.22061098 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.18571051 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.18454849 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.15742542 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 2.14098263 |
| 33 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.13979495 |
| 34 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.12632821 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.10371096 |
| 36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.06725100 |
| 37 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.05283323 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 2.04847453 |
| 39 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.04585203 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03673805 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.00094158 |
| 42 | MAF_26560356_Chip-Seq_TH2_Human | 1.97815323 |
| 43 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.90039890 |
| 44 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.81142882 |
| 45 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.64989372 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64249976 |
| 47 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.56532149 |
| 48 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.50651350 |
| 49 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.48244224 |
| 50 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.48243658 |
| 51 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.46553248 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43345909 |
| 53 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40859296 |
| 54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37965533 |
| 55 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.35679409 |
| 56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33849017 |
| 57 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31705598 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.30862165 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26545078 |
| 60 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25130684 |
| 61 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.25126495 |
| 62 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24769379 |
| 63 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23492987 |
| 64 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19612050 |
| 65 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14853690 |
| 66 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14081660 |
| 67 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.13117811 |
| 68 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.08488047 |
| 69 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05425687 |
| 70 | GATA3_26560356_Chip-Seq_TH2_Human | 1.05014320 |
| 71 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04548554 |
| 72 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04137922 |
| 73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03633900 |
| 74 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03311911 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01537006 |
| 76 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01067729 |
| 77 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00275593 |
| 78 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99912505 |
| 79 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.98182442 |
| 80 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.98014342 |
| 81 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97701396 |
| 82 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96763827 |
| 83 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96733912 |
| 84 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.95382409 |
| 85 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.94369100 |
| 86 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91849962 |
| 87 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88882548 |
| 88 | GATA1_22025678_ChIP-Seq_K562_Human | 0.88655505 |
| 89 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.88019267 |
| 90 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87887742 |
| 91 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87819553 |
| 92 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87436245 |
| 93 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86996447 |
| 94 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86542939 |
| 95 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84400851 |
| 96 | KDM2B_26808549_Chip-Seq_K562_Human | 0.83864629 |
| 97 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.83289489 |
| 98 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.82999790 |
| 99 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81461480 |
| 100 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80834028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 3.90181990 |
| 2 | MP0003303_peritoneal_inflammation | 3.72912816 |
| 3 | MP0003724_increased_susceptibility_to | 3.70096685 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.29749839 |
| 5 | MP0005451_abnormal_body_composition | 2.92464183 |
| 6 | MP0001800_abnormal_humoral_immune | 2.80775150 |
| 7 | MP0003763_abnormal_thymus_physiology | 2.77547926 |
| 8 | MP0005671_abnormal_response_to | 2.69743334 |
| 9 | MP0001790_abnormal_immune_system | 2.69044301 |
| 10 | MP0005387_immune_system_phenotype | 2.69044301 |
| 11 | MP0002419_abnormal_innate_immunity | 2.68871594 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.66143221 |
| 13 | MP0005025_abnormal_response_to | 2.61718463 |
| 14 | MP0009785_altered_susceptibility_to | 2.61661007 |
| 15 | MP0002723_abnormal_immune_serum | 2.46631236 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.35925650 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.32468441 |
| 18 | MP0000685_abnormal_immune_system | 2.32235070 |
| 19 | MP0001819_abnormal_immune_cell | 2.30265455 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.25150633 |
| 21 | MP0006082_CNS_inflammation | 2.21280307 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 2.13308441 |
| 23 | MP0002132_abnormal_respiratory_system | 2.09424429 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.03045155 |
| 25 | MP0005464_abnormal_platelet_physiology | 1.98687925 |
| 26 | MP0009278_abnormal_bone_marrow | 1.95428954 |
| 27 | MP0002398_abnormal_bone_marrow | 1.95338152 |
| 28 | MP0002405_respiratory_system_inflammati | 1.94870097 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.91593871 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.84809771 |
| 31 | MP0000716_abnormal_immune_system | 1.84550010 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.82262671 |
| 33 | MP0004510_myositis | 1.78537423 |
| 34 | MP0003828_pulmonary_edema | 1.78164254 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.77462664 |
| 36 | MP0008260_abnormal_autophagy | 1.76408383 |
| 37 | MP0004947_skin_inflammation | 1.75507032 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.58363680 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.57754573 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.55557497 |
| 41 | MP0000703_abnormal_thymus_morphology | 1.54063656 |
| 42 | MP0002722_abnormal_immune_system | 1.52623047 |
| 43 | MP0001851_eye_inflammation | 1.52313617 |
| 44 | MP0002332_abnormal_exercise_endurance | 1.46600421 |
| 45 | MP0002277_abnormal_respiratory_mucosa | 1.45610190 |
| 46 | MP0005058_abnormal_lysosome_morphology | 1.45392106 |
| 47 | MP0002429_abnormal_blood_cell | 1.44377876 |
| 48 | MP0008469_abnormal_protein_level | 1.40233057 |
| 49 | MP0004130_abnormal_muscle_cell | 1.40106815 |
| 50 | MP0002396_abnormal_hematopoietic_system | 1.39965200 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.39666366 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.37048568 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.35997669 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.35997669 |
| 55 | MP0004883_abnormal_blood_vessel | 1.35035707 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.34519564 |
| 57 | MP0001853_heart_inflammation | 1.32784510 |
| 58 | MP0009764_decreased_sensitivity_to | 1.27957816 |
| 59 | MP0004808_abnormal_hematopoietic_stem | 1.25050272 |
| 60 | MP0004145_abnormal_muscle_electrophysio | 1.24748036 |
| 61 | MP0003646_muscle_fatigue | 1.21208297 |
| 62 | MP0000858_altered_metastatic_potential | 1.14928743 |
| 63 | MP0003075_altered_response_to | 1.14867280 |
| 64 | MP0001873_stomach_inflammation | 1.14080952 |
| 65 | MP0005310_abnormal_salivary_gland | 1.10878564 |
| 66 | MP0004381_abnormal_hair_follicle | 1.10116306 |
| 67 | MP0003866_abnormal_defecation | 1.08355963 |
| 68 | MP0005166_decreased_susceptibility_to | 1.07278738 |
| 69 | MP0005164_abnormal_response_to | 1.03893947 |
| 70 | MP0004185_abnormal_adipocyte_glucose | 1.03340432 |
| 71 | MP0009763_increased_sensitivity_to | 1.01833678 |
| 72 | MP0008004_abnormal_stomach_pH | 1.01754102 |
| 73 | MP0002009_preneoplasia | 0.91348770 |
| 74 | MP0002933_joint_inflammation | 0.90421552 |
| 75 | MP0005666_abnormal_adipose_tissue | 0.89779982 |
| 76 | MP0003448_altered_tumor_morphology | 0.87548068 |
| 77 | MP0003806_abnormal_nucleotide_metabolis | 0.85401825 |
| 78 | MP0005076_abnormal_cell_differentiation | 0.85202371 |
| 79 | MP0004036_abnormal_muscle_relaxation | 0.85014226 |
| 80 | MP0003690_abnormal_glial_cell | 0.83144811 |
| 81 | MP0000249_abnormal_blood_vessel | 0.82143391 |
| 82 | MP0003091_abnormal_cell_migration | 0.82141415 |
| 83 | MP0009765_abnormal_xenobiotic_induced | 0.81523271 |
| 84 | MP0000343_altered_response_to | 0.80500229 |
| 85 | MP0002106_abnormal_muscle_physiology | 0.79748110 |
| 86 | MP0004087_abnormal_muscle_fiber | 0.77228754 |
| 87 | MP0000490_abnormal_crypts_of | 0.76397304 |
| 88 | MP0001663_abnormal_digestive_system | 0.75890501 |
| 89 | MP0000747_muscle_weakness | 0.74990064 |
| 90 | MP0000749_muscle_degeneration | 0.74623145 |
| 91 | MP0002166_altered_tumor_susceptibility | 0.74501402 |
| 92 | MP0003221_abnormal_cardiomyocyte_apopto | 0.74003229 |
| 93 | MP0000751_myopathy | 0.72836427 |
| 94 | MP0005390_skeleton_phenotype | 0.68830594 |
| 95 | MP0003453_abnormal_keratinocyte_physiol | 0.67431519 |
| 96 | MP0003045_fibrosis | 0.65718134 |
| 97 | MP0000759_abnormal_skeletal_muscle | 0.65459442 |
| 98 | MP0008961_abnormal_basal_metabolism | 0.64853221 |
| 99 | MP0005266_abnormal_metabolism | 0.63754577 |
| 100 | MP0008874_decreased_physiological_sensi | 0.63726834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.19909366 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.78433525 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.68944866 |
| 4 | Myositis (HP:0100614) | 4.45895816 |
| 5 | Stomatitis (HP:0010280) | 4.33683154 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.11267499 |
| 7 | Muscle fiber inclusion bodies (HP:0100299) | 3.92743264 |
| 8 | Abnormality of macrophages (HP:0004311) | 3.91194595 |
| 9 | Nemaline bodies (HP:0003798) | 3.86855740 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 3.81058440 |
| 11 | Optic neuritis (HP:0100653) | 3.81058440 |
| 12 | Orchitis (HP:0100796) | 3.79705827 |
| 13 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.79475464 |
| 14 | Nasal polyposis (HP:0100582) | 3.73874517 |
| 15 | Exercise-induced myalgia (HP:0003738) | 3.73220257 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.69636278 |
| 17 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.67556401 |
| 18 | Absent/shortened dynein arms (HP:0200106) | 3.54179713 |
| 19 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.54179713 |
| 20 | Mediastinal lymphadenopathy (HP:0100721) | 3.49882821 |
| 21 | Recurrent fungal infections (HP:0002841) | 3.41842415 |
| 22 | Meningitis (HP:0001287) | 3.41759937 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.25097592 |
| 24 | Prolonged bleeding time (HP:0003010) | 3.23445352 |
| 25 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.22157458 |
| 26 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.22157458 |
| 27 | Abnormality of the nasal mucosa (HP:0000433) | 3.15730779 |
| 28 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.14730068 |
| 29 | Panhypogammaglobulinemia (HP:0003139) | 3.13511243 |
| 30 | Spontaneous hematomas (HP:0007420) | 3.10212192 |
| 31 | Abnormal ciliary motility (HP:0012262) | 3.09959622 |
| 32 | Recurrent skin infections (HP:0001581) | 3.07700705 |
| 33 | Increased IgE level (HP:0003212) | 3.04380057 |
| 34 | Obstructive lung disease (HP:0006536) | 3.03129860 |
| 35 | Chronic obstructive pulmonary disease (HP:0006510) | 3.03129860 |
| 36 | Recurrent viral infections (HP:0004429) | 3.01432083 |
| 37 | Muscle fiber splitting (HP:0003555) | 3.00793122 |
| 38 | T lymphocytopenia (HP:0005403) | 2.96389164 |
| 39 | Encephalitis (HP:0002383) | 2.94475192 |
| 40 | Recurrent sinusitis (HP:0011108) | 2.93178182 |
| 41 | Gastrointestinal infarctions (HP:0005244) | 2.82589292 |
| 42 | Keratoconjunctivitis sicca (HP:0001097) | 2.82333744 |
| 43 | Vasculitis (HP:0002633) | 2.81811328 |
| 44 | Bronchiectasis (HP:0002110) | 2.75664624 |
| 45 | Difficulty running (HP:0009046) | 2.75659158 |
| 46 | Chronic otitis media (HP:0000389) | 2.75521998 |
| 47 | Rhinitis (HP:0012384) | 2.69790614 |
| 48 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.69127144 |
| 49 | Recurrent cutaneous fungal infections (HP:0011370) | 2.69127144 |
| 50 | Abnormality of T cell number (HP:0011839) | 2.66799734 |
| 51 | Epistaxis (HP:0000421) | 2.58442652 |
| 52 | Gingivitis (HP:0000230) | 2.58323992 |
| 53 | Chest pain (HP:0100749) | 2.53841951 |
| 54 | Recurrent bronchitis (HP:0002837) | 2.52715870 |
| 55 | Cellulitis (HP:0100658) | 2.49975240 |
| 56 | Pustule (HP:0200039) | 2.49349724 |
| 57 | Inflammation of the large intestine (HP:0002037) | 2.48595010 |
| 58 | Purpura (HP:0000979) | 2.47626389 |
| 59 | Gastrointestinal inflammation (HP:0004386) | 2.45474556 |
| 60 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.44615746 |
| 61 | Recurrent otitis media (HP:0000403) | 2.42988504 |
| 62 | Keratoconjunctivitis (HP:0001096) | 2.42805764 |
| 63 | Bronchitis (HP:0012387) | 2.41120743 |
| 64 | Granulocytopenia (HP:0001913) | 2.36835212 |
| 65 | Arterial thrombosis (HP:0004420) | 2.34515327 |
| 66 | Gingival bleeding (HP:0000225) | 2.31641711 |
| 67 | Ulnar deviation of the wrist (HP:0003049) | 2.31307494 |
| 68 | Leukocytosis (HP:0001974) | 2.30037518 |
| 69 | Myopathic facies (HP:0002058) | 2.29375268 |
| 70 | Type 1 muscle fiber predominance (HP:0003803) | 2.26767707 |
| 71 | Agammaglobulinemia (HP:0004432) | 2.24740330 |
| 72 | Abnormality of T cells (HP:0002843) | 2.24647048 |
| 73 | Chronic bronchitis (HP:0004469) | 2.24255102 |
| 74 | Colitis (HP:0002583) | 2.23462697 |
| 75 | Papilledema (HP:0001085) | 2.22764111 |
| 76 | Increased serum ferritin (HP:0003281) | 2.22692308 |
| 77 | Pulmonary infiltrates (HP:0002113) | 2.18254698 |
| 78 | Urticaria (HP:0001025) | 2.17232517 |
| 79 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.13806266 |
| 80 | Hemoptysis (HP:0002105) | 2.12295433 |
| 81 | Pulmonary embolism (HP:0002204) | 2.11607105 |
| 82 | Chronic sinusitis (HP:0011109) | 2.10315530 |
| 83 | Episodic fever (HP:0001954) | 2.07528034 |
| 84 | Obstructive sleep apnea (HP:0002870) | 2.07455247 |
| 85 | EMG: myopathic abnormalities (HP:0003458) | 2.06929769 |
| 86 | Hypochromic anemia (HP:0001931) | 2.04624670 |
| 87 | IgM deficiency (HP:0002850) | 2.03989706 |
| 88 | Abnormality of the fingertips (HP:0001211) | 2.02612869 |
| 89 | Distal lower limb muscle weakness (HP:0009053) | 2.02185017 |
| 90 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.00674673 |
| 91 | Subaortic stenosis (HP:0001682) | 2.00674673 |
| 92 | Eosinophilia (HP:0001880) | 1.99647266 |
| 93 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.99108885 |
| 94 | Asymmetric septal hypertrophy (HP:0001670) | 1.98520556 |
| 95 | Anorexia (HP:0002039) | 1.98315634 |
| 96 | Hypochromic microcytic anemia (HP:0004840) | 1.98089836 |
| 97 | Autoimmune hemolytic anemia (HP:0001890) | 1.97257107 |
| 98 | Lymphopenia (HP:0001888) | 1.97081649 |
| 99 | Gangrene (HP:0100758) | 1.96323731 |
| 100 | Exercise-induced muscle cramps (HP:0003710) | 1.92023501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.06312267 |
| 2 | MAP4K1 | 3.51565177 |
| 3 | PRPF4B | 3.18045974 |
| 4 | MAP2K3 | 2.82700491 |
| 5 | BLK | 2.82220082 |
| 6 | TYK2 | 2.66647585 |
| 7 | IRAK4 | 2.61929502 |
| 8 | ZAP70 | 2.29728500 |
| 9 | CSK | 2.23517780 |
| 10 | OBSCN | 2.21695521 |
| 11 | MAPK15 | 2.09520725 |
| 12 | TXK | 2.03534193 |
| 13 | TNK2 | 2.03440581 |
| 14 | MAP3K14 | 1.96077321 |
| 15 | IKBKE | 1.90106958 |
| 16 | TBK1 | 1.86162998 |
| 17 | ERN1 | 1.84916114 |
| 18 | FES | 1.78432339 |
| 19 | TAOK1 | 1.76295809 |
| 20 | MAP3K13 | 1.72279161 |
| 21 | BTK | 1.70955804 |
| 22 | TTN | 1.67336285 |
| 23 | MAP3K3 | 1.59470893 |
| 24 | GRK6 | 1.58043321 |
| 25 | JAK3 | 1.54266696 |
| 26 | SYK | 1.45921098 |
| 27 | HCK | 1.44988753 |
| 28 | EPHB1 | 1.41614911 |
| 29 | TRIB3 | 1.39115725 |
| 30 | MAPK12 | 1.34432520 |
| 31 | JAK1 | 1.32176829 |
| 32 | MAP3K7 | 1.25626781 |
| 33 | MAP3K10 | 1.25250349 |
| 34 | TEC | 1.23959397 |
| 35 | MARK2 | 1.22981260 |
| 36 | ITK | 1.19690195 |
| 37 | SMG1 | 1.19662068 |
| 38 | LCK | 1.19521825 |
| 39 | CDC42BPA | 1.14989971 |
| 40 | IRAK1 | 1.13498378 |
| 41 | SIK3 | 1.12371507 |
| 42 | LYN | 1.08371919 |
| 43 | FGR | 1.08319160 |
| 44 | CDK12 | 1.07290194 |
| 45 | JAK2 | 1.03531579 |
| 46 | MAP3K1 | 1.03047684 |
| 47 | PIK3CG | 1.02464166 |
| 48 | TAOK3 | 1.00041135 |
| 49 | MARK3 | 0.96540173 |
| 50 | KIT | 0.95369121 |
| 51 | TAOK2 | 0.93972553 |
| 52 | IRAK2 | 0.93901265 |
| 53 | STK10 | 0.93019338 |
| 54 | HIPK2 | 0.91910809 |
| 55 | SIK2 | 0.91609312 |
| 56 | MAPK7 | 0.91390101 |
| 57 | NLK | 0.90629663 |
| 58 | CSF1R | 0.88064593 |
| 59 | IKBKB | 0.86587280 |
| 60 | MAP3K11 | 0.84968761 |
| 61 | MAP3K6 | 0.81810495 |
| 62 | PRKCQ | 0.80358566 |
| 63 | PDK1 | 0.73448146 |
| 64 | SIK1 | 0.72691629 |
| 65 | FGFR4 | 0.69251653 |
| 66 | FGFR3 | 0.69148170 |
| 67 | CDK19 | 0.68938782 |
| 68 | MATK | 0.66416112 |
| 69 | TGFBR2 | 0.64595819 |
| 70 | YES1 | 0.64436995 |
| 71 | KSR2 | 0.64244341 |
| 72 | BMPR2 | 0.61943968 |
| 73 | PRKD2 | 0.61411047 |
| 74 | DYRK1B | 0.57769818 |
| 75 | PDPK1 | 0.55689555 |
| 76 | SGK3 | 0.54213669 |
| 77 | CDK4 | 0.53906481 |
| 78 | CDK6 | 0.53251203 |
| 79 | CDK9 | 0.53170909 |
| 80 | SGK2 | 0.51715085 |
| 81 | RPS6KC1 | 0.50187373 |
| 82 | RPS6KL1 | 0.50187373 |
| 83 | STK24 | 0.49399997 |
| 84 | MELK | 0.42788598 |
| 85 | MAP3K5 | 0.42778240 |
| 86 | MAPK4 | 0.41657683 |
| 87 | STK11 | 0.41186075 |
| 88 | CAMK4 | 0.41046817 |
| 89 | STK38 | 0.41023375 |
| 90 | CHUK | 0.40878624 |
| 91 | FYN | 0.40505688 |
| 92 | MOS | 0.40396387 |
| 93 | BMPR1B | 0.39837527 |
| 94 | CDK8 | 0.39777179 |
| 95 | PIM1 | 0.38074523 |
| 96 | PTK6 | 0.36872914 |
| 97 | MAP2K4 | 0.36676982 |
| 98 | GRK7 | 0.36672190 |
| 99 | DYRK3 | 0.36432789 |
| 100 | MAP2K6 | 0.36276996 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.95116355 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.68603683 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.54969693 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.44065904 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.38899086 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.21015612 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.16732666 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.12709268 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.08998592 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.03545471 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.97920193 |
| 12 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.97217748 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.90821859 |
| 14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.89573098 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.88837027 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.88574968 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.83719102 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.83490765 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.80363150 |
| 20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.65928392 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.65269432 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.63682065 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.59125714 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.55660139 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.55423283 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.48978754 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46198231 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44631106 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.43323829 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.39047942 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.37907777 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.34342765 |
| 33 | Asthma_Homo sapiens_hsa05310 | 1.32002714 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.28308787 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27768184 |
| 36 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.19640820 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 1.19080032 |
| 38 | Legionellosis_Homo sapiens_hsa05134 | 1.18818917 |
| 39 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.18213517 |
| 40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.17535460 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 1.17410315 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.17199642 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 1.15059483 |
| 44 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.14001983 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09463321 |
| 46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.08510407 |
| 47 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.05800223 |
| 48 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03509963 |
| 49 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.00984374 |
| 50 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.94939474 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.94212674 |
| 52 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.93796208 |
| 53 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.93319053 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89357123 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88749918 |
| 56 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87937618 |
| 57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.84850889 |
| 58 | Insulin resistance_Homo sapiens_hsa04931 | 0.83285888 |
| 59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.82583878 |
| 60 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.79165138 |
| 61 | Apoptosis_Homo sapiens_hsa04210 | 0.77494184 |
| 62 | Amoebiasis_Homo sapiens_hsa05146 | 0.77158748 |
| 63 | Colorectal cancer_Homo sapiens_hsa05210 | 0.76478830 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76098551 |
| 65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.75878418 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.74504726 |
| 67 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.74204851 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73997497 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 0.73887393 |
| 70 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.73827101 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.73250495 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68791096 |
| 73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66817092 |
| 74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.65551485 |
| 75 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64195738 |
| 76 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.62919597 |
| 77 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.62091465 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61571988 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61289704 |
| 80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60940888 |
| 81 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59712049 |
| 82 | Shigellosis_Homo sapiens_hsa05131 | 0.58052464 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56773029 |
| 84 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55875746 |
| 85 | Lysosome_Homo sapiens_hsa04142 | 0.54615570 |
| 86 | Prostate cancer_Homo sapiens_hsa05215 | 0.53322075 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52153535 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.50112915 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49963321 |
| 90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49380208 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47437443 |
| 92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46233064 |
| 93 | Long-term potentiation_Homo sapiens_hsa04720 | 0.45964111 |
| 94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.45141657 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43662508 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41277217 |
| 97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36546328 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35426156 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32271988 |
| 100 | Prion diseases_Homo sapiens_hsa05020 | 0.32245220 |

